Back to

This week in vaccines – 1 July 2018

After the announcement that Ebola outbreak in DRC has been largely contained, Scientific American discussed how the vaccine transformed the outbreak response. Meanwhile, Forbes praised the pharmaceutical industry’s role in Ebola vaccine development and The Guardian looked ahead to how the Global Virome Project could help tackle the next pandemic threat.

Measles reentered the global stage as the Pan-American Health Organization (PAHO) called for urgent action to halt the transmission of measles and diphtheria in crisis-hit Venezuela, whilst the ongoing epidemic in France claimed another life.

In the week that Papua New Guinea saw its first polio case in eighteen years, ABC argued that eradicating polio is both political and personal, and Canadian Prime Minister Justin Trudeau received a Rotary Polio Eradication Champion Award for his commitment to ending the disease. Meanwhile, a study found that a modified polio vaccine could help some brain tumour patients survive longer.

Also this week, as Uganda introduced the rotavirus vaccine into its routine immunisation schedule, a paper published in Vaccine looked at the impact of rotavirus vaccines in sub-Saharan Africa.

Elsewhere in research, a high-resolution snapshot of the Zika virus could reveal clues to developing better vaccines against the disease, and a study showed that intermediate levels of vaccine coverage may minimise seasonal flu outbreaks. 

Subscribe to our newsletter